Pharmacologic treatment of geriatric depression: Key issues in interpreting the evidence

Journal of the American Geriatrics Society

Volumn 46, Issue 1, 1998, Pages 106-110

  Rigler, Sally K ^a,b   Studenski, Stephanie ^b   Duncan, Pamela W ^b,c,d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICHOLINERGIC EFFECT; ARTICLE; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL TOXICITY; GERIATRICS; HUMAN; INDEPENDENCE; OUTCOMES RESEARCH; QUALITY OF LIFE; RATING SCALE; SELF CARE; SIDE EFFECT; WELLBEING;

EID: 0031964394     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb01023.x     Document Type: Article

References (27)

1. Guyatt GH, Sackett DL, Cook DJ, for the Evidenced-Based Working Group. User's guides to the medical literature, II: How to use an article about therapy or prevention. A: Are the results of the study valid? JAMA 1993;270:2598-2601.
2. Guyatt GH, Sackett DL, Cook DJ, for the Evidenced-Based Working Group. User's guides to the medical literature, II: How to use an article about therapy or prevention. B: What were the results and will they help me in caring for my patients? JAMA 1994;271:59-63.
3. NIH Consensus Conference. Diagnosis and treatment of depression in late life. JAMA 1992;268:1018-1024.
4. Finkel SI. Efficacy and tolerability of antidepressant therapy in the old-old. J Clin Psychiatry 1996;57(suppl 5):23-28.
5. Gerson SC, Plotkin DA, Jarvik LF. Antidepressant drug studies, 1964 to 1986: Empirical evidence for aging patients. J Clin Psychopharmacol 1988;8:311-322.
6. Schneider LS. Pharmacologic considerations in the treatment of late-life depression. Am J Geriatr Psychiatry 1996;4(suppl 1):51-65.
7. Burvill PW, Stampfer HG, Hall WD. Issues in the assessment of outcome in depressive illness in the elderly. Int J Geriatr Psychiatry 1991;6:269-277.
8. Agency for Health Care Policy and Research. Depression in primary care: Vol. 1. Detection and Diagnosis; Vol.2. Treatment of Major Depression. Rockville, MD: AHCPR, 1994.
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
10. Katz IR. Drug treatment of depression in the frail elderly: Discussion of the NIH consensus development conference on the diagnosis and treatment of depression in late life. Psychopharmacol Bull 1993;29:101-108.
11. Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:53-63.
12. Teri L, Logsdon R. Methodologic issues regarding outcome measures for clinical drug trials of psychiatric complications in dementia. J Geriatr Psychiatry Neurol 1995;8(suppl 1):8-17.
13. Yesavage JA, Brink TL, Rose TL et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1983;17:37-49.
14. Montorio I, Izal M. The Geriatric Depression Scale: A review of its development and utility. Int Psychogeriatr 1996;8:103-112.
15. McGivney SA, Mulvihill M, Taylor B. Validating the GDS depression screen in the nursing home. J Am Geriatr Soc 1994;42:490-492.
16. Beusterien KM, Steinwald B, Ware JE Jr. Usefulness of the SF-36 health survey in measuring health outcomes in the depressed elderly. J Geriatr Psychiatry Neurol 1996;9:13-21.
17. Bech P, Gram LF, Dein E et al. Quantitative rating of depressive states. Acta Psychiatr Scand 1975;51:161-170.
18. Cohn CK, Shrivastava R, Mendels J. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990;5(12, suppl B):28-33.
19. Dunner DL, Cohn JB, Walshe T III et al. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry 1992;53(suppl 2):57-60.
20. Feighner JP, Cohn JB. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1975;46(3, sec 2):20-25.
21. Koenig HG, Goli V, Shelp F et al. Antidepressant use in elderly medical inpatients: Lessons from an attempted clinical trial. J Gen Intern Med 1989;4:498-505.
22. Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry 1996;57(suppl 5):38-44.
23. Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): 1. Conceptual framework and item selection. Med Care 1992;30:473-483.
24. Hays RD, Wells KB, Sherbourne CD et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry 1995;52:11-19.
25. Wells KB, Steward A, Hays RD et al. The functioning and well-being of depressed patients: Results from the medical outcomes study. JAMA 1989;262:914-919.
26. Burvill PW, Mowry B, Hall W. Quantification of physical illness in psychiatric research in the elderly. Int J Geriatr Psychiatry 1990;5:161-170.
27. Wells KB, Rogers W, Burnam MA et al. How the medical comorbidity of depressed patients differs across health care settings: Results from the medical outcomes study. Am J Psychiatry 1991;148:1688-1696.